13F filer · CIK 1037792 ↗
Paradigm Capital Management Inc
You are looking at Q1 2026. See the latest, Q2 2026 →
Reported value
$2.61B
+10% on the quarter before
Positions
112
0 new · 4 sold out
Top 10
61.5%
of the value
Est. gain
+$228.4M
on stocks held all quarter
Est. return
+10.0%
on those stocks since Q4 2025
Positions as of Mar 31, 2026, from Paradigm Capital Management Inc's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q4 2025. Striped tiles are options.
Largest buys
Since Q4 2025, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Enovis Corporation~$16.7MAdded · 1.2% → 1.5%+732,917 shares
- Integra Lifesciences Holdings Corp~$12.7MAdded · 1.4% → 1.4%+1,347,700 shares
- Penguin Solutions~$12.0MAdded · 0.8% → 1.1%+681,700 shares
- Quidel Corp~$11.5MAdded · 1.0% → 1.0%+697,010 shares
- Insight Enterprises~$9.7MAdded · 2.8% → 2.5%+145,169 shares
- Si-Bone, Inc.~$7.6MAdded · 0.4% → 0.5%+598,300 shares
- Dentsply Sirona, Inc.~$6.7MAdded · 1.2% → 1.3%+578,700 shares
- Bath & Body Works, Inc.~$5.2MAdded · 0.2% → 0.3%+281,100 shares
- Helen Of Troy Limited~$5.2MAdded · 0.5% → 0.5%+362,900 shares
- Calix~$4.7MAdded · 1.5% → 1.4%+95,800 shares
Largest sells
Since Q4 2025, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Enviri Corp~$25.7MCut · 2.7% → 1.7%−1,312,400 shares
- Tactile Systems Technology~$12.6MCut · 0.9% → 0.3%−480,700 shares
- Globus Medical~$10.6MCut · 3.5% → 2.7%−123,500 shares
- Cohu~$8.9MCut · 0.9% → 0.7%−291,045 shares
- Veeco~$7.8MCut · 2.9% → 2.8%−229,100 shares
- Adtran Inc~$5.0MCut · 0.4% → 0.4%−396,709 shares
- Onto Innovation~$4.8MCut · 7.5% → 8.6%−23,400 shares
- Modine~$4.5MCut · 8.3% → 12.1%−20,700 shares
- Trubridge, Inc.~$4.2MCut · 0.3% → 0.0%−286,938 shares
- Enersys~$4.2MCut · 2.9% → 2.9%−23,900 shares
Holdings
As of Mar 31, 2026. Changes are in shares against Dec 31, 2025, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ModineCOM · shares −1.4% · price +62.3% | 12.1% | $315.4M | +$121.1M | ||||||||
| FabrinetCOM · shares 0% · price +14.5% | 10.6% | $276.7M | +$35.1M | ||||||||
| BroadcomCOM · shares 0% · price −10.6% | 9.6% | $250.4M | −$29.6M | ||||||||
| Onto InnovationCOM · shares −2.1% · price +29.9% | 8.6% | $226.1M | +$52.0M | ||||||||
| JabilCOM · shares −1.8% · price +16.5% | 5.6% | $145.5M | +$20.6M | ||||||||
| Ducommun IncCOM · shares 0% · price +28.2% | 3.6% | $94.0M | +$20.7M | ||||||||
| Extreme NetworksCOM · shares +5.3% · price −9.4% | 3.0% | $78.9M | −$7.8M | ||||||||
| EnersysCOM · shares −5.1% · price +18.4% | 2.9% | $76.8M | +$11.9M | ||||||||
| VeecoCOM · shares −9.5% · price +18.5% | 2.8% | $73.5M | +$11.5M | ||||||||
| Globus MedicalCOM · shares −13% · price −1.3% | 2.7% | $70.8M | −$945,644 | ||||||||
| Ensign Group, Inc.COM · shares −0.6% · price +15.7% | 2.6% | $68.9M | +$9.3M | ||||||||
| Insight EnterprisesCOM · shares +18% · price −17.7% | 2.5% | $64.1M | −$11.7M | ||||||||
| EntegrisCOM · shares −1.9% · price +39.2% | 2.3% | $61.4M | +$17.3M | ||||||||
| Enviri CorpCOM · shares −37% · price +9.5% | 1.7% | $43.8M | +$3.8M | ||||||||
| Pennant Group Inc.COM · shares −0.3% · price +8.3% | 1.6% | $42.9M | +$3.3M | ||||||||
| Enovis CorporationCOM · shares +70% · price −14.6% | 1.5% | $40.4M | −$4.1M | ||||||||
| Orthofix Medical Inc.COM · shares 0% · price −24.3% | 1.5% | $37.9M | −$12.2M | ||||||||
| UCT (Ultra Clean Holdings)COM · shares 0% · price +145.5% | 1.4% | $37.8M | +$22.4M | ||||||||
| Integra Lifesciences Holdings CorpCOM · shares +51% · price −24.2% | 1.4% | $37.8M | −$8.0M | ||||||||
| CalixCOM · shares +14% · price −7.4% | 1.4% | $37.6M | −$2.6M | ||||||||
| Dentsply Sirona, Inc.COM · shares +24% · price +1.5% | 1.3% | $34.5M | +$407,745 | ||||||||
| Penguin SolutionsCOM · shares +74% · price −10.0% | 1.1% | $28.2M | −$1.8M | ||||||||
| Quidel CorpCOM · shares +84% · price −42.5% | 0.96% | $25.1M | −$10.1M | ||||||||
| LumentumCOM · shares 0% · price +90.7% | 0.90% | $23.6M | +$11.2M | ||||||||
| CohuCOM · shares −32% · price +31.6% | 0.73% | $19.1M | +$4.6M | ||||||||
| Total · 112 positions | 100% | $2.61B | +$228.4M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2025 to Q1 2026: 112 stocks held throughout, up $228.4M (+10.0%).
- Modine+$121.1M+62%
- Onto Innovation+$52.0M+30%
- Fabrinet+$35.1M+15%
- UCT (Ultra Clean Holdings)+$22.4M+145%
- Ducommun Inc+$20.7M+28%
- Cerence−$8.9M−41%
- Quidel Corp−$10.1M−42%
- Insight Enterprises−$11.7M−18%
- Orthofix Medical Inc.−$12.2M−24%
- Broadcom−$29.6M−11%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | $3.67B+41% | SEC ↗ |
| Q1 2026 | May 14, 2026 | $2.61B+10% | SEC ↗ |
| Q4 2025 | Feb 12, 2026 | $2.38B+3% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $2.31B+12% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $2.05B+14% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $1.80B−17% | SEC ↗ |
| Q4 2024 | Feb 18, 2025 | $2.16B−4% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $2.25B+3% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $2.19B+5% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $2.09B+9% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $1.92B+10% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $1.74B−0% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $1.75B+16% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $1.51B−0% | SEC ↗ |
| Q4 2022 | Feb 3, 2023 | $1.51B+9% | SEC ↗ |
| Q3 2022 | Oct 26, 2022 | $1.39B−6% | SEC ↗ |
| Q2 2022 | Aug 2, 2022 | $1.47B−20% | SEC ↗ |
| Q1 2022 | May 25, 2022 | $1.85B−17% | SEC ↗ |
| Q4 2021 | Feb 9, 2022 | $2.24B+15% | SEC ↗ |
| Q3 2021 | Nov 8, 2021 | $1.94B−7% | SEC ↗ |
| Q2 2021 | Aug 5, 2021 | $2.08B+8% | SEC ↗ |
| Q1 2021 | May 5, 2021 | $1.93B+15% | SEC ↗ |
| Q4 2020 | Jan 20, 2021 | $1.67B+41% | SEC ↗ |
| Q3 2020 | Oct 20, 2020 | $1.19B+9% | SEC ↗ |
| Q2 2020 | Aug 3, 2020 | $1.09B+32% | SEC ↗ |
| Q1 2020 | May 12, 2020 | $827.9M−36% | SEC ↗ |
| Q4 2019 | Feb 5, 2020 | $1.30B+16% | SEC ↗ |
| Q3 2019 | Nov 7, 2019 | $1.12B+2% | SEC ↗ |
| Q2 2019 | Aug 8, 2019 | $1.10B−4% | SEC ↗ |
| Q1 2019 | May 10, 2019 | $1.14B+12% | SEC ↗ |
| Q4 2018 | Feb 8, 2019 | $1.02B−20% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $1.27B+3% | SEC ↗ |
| Q2 2018 | Aug 8, 2018 | $1.24B+5% | SEC ↗ |
| Q1 2018 | Apr 9, 2018 | $1.18B+1% | SEC ↗ |
| Q4 2017 | Feb 7, 2018 | $1.17B+2% | SEC ↗ |
| Q3 2017 | Nov 6, 2017 | $1.15B+4% | SEC ↗ |
| Q2 2017 | Aug 10, 2017 | $1.11B+5% | SEC ↗ |
| Q1 2017 | May 9, 2017 | $1.06B+3% | SEC ↗ |
| Q4 2016 | Feb 13, 2017 | $1.03B+8% | SEC ↗ |
| Q3 2016 | Nov 10, 2016 | $953.0M+16% | SEC ↗ |
| Q2 2016 | Aug 9, 2016 | $820.6M−4% | SEC ↗ |
| Q1 2016 | May 12, 2016 | $858.8M | SEC ↗ |